Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 293-671-6 | CAS number: 91081-64-0 Slag produced during ilmenite smelting (ore or sand). Consists primarly of TiO2, FeO, Al2O3, SiO2, MgO and other metal oxides.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
UGI (Upgraded Ilmenite) consists primarily of a titanate phase (solid solution) most of which is Ti in an oxidised form. Upon uptake into the body, a low rate of dissolution in the respiratory or gastrointestinal tracts is assumed, based on the experimental verified inertness of the material in artificial physiological media. Any material being released from UGI under physiological conditions will thus be in the form of ionic Ti, which is similarly the case for titanium dioxide: more specifically, the results from in vitro bioaccessibility testing in such fluids demonstrate a similar dissolution pattern of UGI and titanium dioxide (see summary reported under point 7.1.1 basic toxicokinetics), thus read-across from genotoxicity data on titanium dioxide is considered feasible without any restrictions.
In vitro genetic toxicity tests
It is concluded that titanium dioxide did not induce micronuclei in cultured human peripheral blood lymphocytes following treatments in the absence and presence of an Aroclor induced rat liver metabolic activation system (S-9). Concentrations were tested and analysed up to and in excess of the solubility limit in culture medium.
It is concluded that titanium dioxide did not induce mutation at the tk locus of L5178Y mouse lymphoma cells when tested under the conditions employed in this study up to 500µg/mL. These conditions included treatments up to precipitating concentrations in two independent experiments, in the absence and presence of a rat liver metabolic activation system (S-9). Furthermore titanium dioxide did not induce chromosome aberrations in chinese hamster ovary cells (CHO) when tested under the conditions employed in this study up to 2500µg/mL. These conditions included treatments up to precipitating concentrations in two independent experiments, in the absence and presence of a rat liver metabolic activation system (S-9).
In vivo genetic toxicity tests
It has been shown that titanium dioxide does not induce micronuclei or chromosome aberration in the bone marrow of male B6C3F1 mice following a single intraperitoneal injection of 1500 and 2500 mg titanium dioxide /kg bw respectively.
It can therefore be concluded thattitanium dioxidedoes not cause genetic toxicity in vitro and in vivo.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Genetic toxicity, in vivo:
The reference Shelby, M.D. (1995) is considered as the key study for in vivo genetic toxicity and will be used for classification. The overall results are as follows:
Titanium dioxide did not show a significant or dose-dependent increase in chromosome aberrations in the bone marrow of male mice via i.p. injection up to the maximum dose of 2500mg/kg bw 17 and 36 hours after dosing.
Titanium dioxide did not show a significant or dose-dependent increase in micronucleated cells in the bone marrow of male mice via i.p. injection up to the maximum dose of 1500mg/kg bw 24 hours after dosing.
Genetic toxicity, in vitro:
None of the in vitro genotoxicity studies rated as reliable showed any effect in bacterial reverse mutation assays, in mammalian cell gene mutation tests (TK assay) or in mammalian cell chromosome aberration tests, thus supporting the negative findings in the in vivo tests as cited above. The classification criteria acc. to regulation (EC) 1272/2008 as germ cell mutagen are also not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
